NTHI Stock Analysis: Buy, Sell, or Hold?
NTHI - NeOnc Technologies Holdings, Inc. Common Stock
$4.35
-0.23 (-5.02%)
▼
5d:
-10.03%
30d:
+5.07%
90d:
-54.83%
HOLD
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 08, 2026
0d
Get Alerted When NTHI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called NTHI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NTHI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NTHI shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NTHI is currently trading at $4.35, which is considered oversold relative to its 30-day fair value range of $4.45 to $5.57.
Technical Outlook: Technically, NTHI is in a strong downtrend. Immediate support is located at $4.16, while resistance sits at $5.66. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: NTHI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.00 (+267.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTHI is in a strong downtrend. Immediate support is located at $4.16, while resistance sits at $5.66. Short-term momentum is weak, with the stock down 5.0% recently.
Market Sentiment: NTHI has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $16.00 (+267.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.45 -
$5.57
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.0%)
- BULLISH: Trading 267.8% below Wall St target ($16.00)
- CAUTION: 5-day price weakness (-10.0%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$4.45 -
$5.57
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.16
Resistance Level
$5.66
Current Trend
Strong Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.77
Wall Street Target
$16.00
(+267.8%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 03, 2026 7:48 PM ET
Data refreshes hourly during market hours. Next update: 8:48 PM
Data refreshes hourly during market hours. Next update: 8:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTHI showing a specific setup today?
Insider Activity (6 Months)
8
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yousha Neman-Ebrahim
BUY
500 shares
2026-04-23
Amir F Heshmatpour
BUY
10000 shares
2026-04-23
Amir F Heshmatpour
BUY
10000 shares
2026-04-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 58 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 53 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |